MLAB · Mesa Laboratories Inc /Co/ · Documents
$125.90
+2.60 (+2.10%)
At close · Oct 20
View the 10-K filed Jun 3, 2026
Return incl. dividend (before tax)
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$690.00M
Shares
5.60M
Volume · Oct 20
77.23K
Avg daily vol (3M)
133.1K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-06 | — | |
| DEF 14A | — | 2020-07-17 | 2020-08-28 | |
| 8-K | — | 2020-06-12 | 2020-06-09 | |
| 8-K | — | 2020-06-04 | 2020-06-01 | |
| 8-K | — | 2020-06-01 | — | |
| 8-K | — | 2020-06-01 | — | |
| 10-K | — | 2020-06-01 | 2020-03-31 | |
| 8-K | — | 2020-05-15 | 2020-05-11 | |
| 8-K | — | 2020-04-02 | 2020-04-01 | |
| 8-K | — | 2020-03-30 | — | |
| 8-K | — | 2020-02-10 | — | |
| 10-Q | — | 2020-02-10 | 2019-12-31 | |
| 8-K/A | — | 2020-01-15 | 2019-10-30 |
Showing 101–114 of 114 filings
Key facts
CIK
724004
CUSIP
59064R109
13F (30d)
16 filings
16 filers
Visit website
Investor relations